Header Logo

XIAO NI

TitleAssociate Professor
InstitutionMD Anderson
DepartmentDermatology
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Velatooru LR, Hu CH, Bijani P, Wang X, Bojaxhi P, Chen H, Duvic M, Ni X. New JAK3-INSL3 Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma. Cells. 2023 09 29; 12(19). PMID: 37830594; PMCID: PMC10572011.
      Citations: 1     Fields:    Translation:HumansAnimals
    2. Ni X, Maiti S, Redko A, Bijani P, Duvic M. Monitoring malignant T-cell clones by direct TCR expression assay in patients with leukemic cutaneous T-cell lymphoma during extracorporeal photopheresis. Photodermatol Photoimmunol Photomed. 2022 Mar; 38(2):158-168. PMID: 34543492.
      Citations:    Fields:    Translation:HumansCells
    3. Ni X, Austin M, Langridge T, Bojaxhi P, Bijani P, Wang X, Duvic M. CD209+ monocyte-derived myeloid dendritic cells were increased in patients with leukemic cutaneous T-cell lymphoma undergoing extracorporeal photopheresis via the CELLEXTM system. Photodermatol Photoimmunol Photomed. 2020 Jul; 36(4):290-298. PMID: 32187738.
      Citations:    Fields:    Translation:HumansCells
    4. Ying Z, Shiue L, Park K, Kollet J, Bijani P, Goswami M, Duvic M, Ni X. Correction: Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma. Oncotarget. 2019 Sep 10; 10(52):5492. PMID: 31534633; PMCID: PMC6739216.
      Citations:    Fields:    
    5. Ying Z, Shiue L, Park K, Kollet J, Bijani P, Goswami M, Duvic M, Ni X. Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma. Oncotarget. 2019 May 07; 10(34):3183-3197. PMID: 31139332; PMCID: PMC6516711.
      Citations:    Fields:    
    6. Ni X, Zhang X, Hu CH, Langridge T, Tarapore RS, Allen JE, Oster W, Duvic M. ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-?B pathways. Oncotarget. 2017 Sep 22; 8(37):61761-61776. PMID: 28977902; PMCID: PMC5617462.
      Citations: 12     Fields:    
    7. Wang L, Ni X, Covington KR, Yang BY, Shiu J, Zhang X, Xi L, Meng Q, Langridge T, Drummond J, Donehower LA, Doddapaneni H, Muzny DM, Gibbs RA, Wheeler DA, Duvic M. Genomic profiling of S?zary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet. 2015 Dec; 47(12):1426-34. PMID: 26551670; PMCID: PMC4829974.
      Citations: 120     Fields:    Translation:HumansCells
    8. Shiue LH, Couturier J, Lewis DE, Wei C, Ni X, Duvic M. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed. 2015 Jul; 31(4):184-94. PMID: 25772268; PMCID: PMC4504772.
      Citations: 7     Fields:    Translation:HumansCells
    9. Ni X, Langridge T, Duvic M. Depletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab. Oncoimmunology. 2015 Jul; 4(7):e1011524. PMID: 26140234; PMCID: PMC4485778.
      Citations: 11     Fields:    
    10. Ni X, Jorgensen JL, Goswami M, Challagundla P, Decker WK, Kim YH, Duvic MA. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and S?zary syndrome. Clin Cancer Res. 2015 Jan 15; 21(2):274-85. PMID: 25376389.
      Citations: 53     Fields:    Translation:HumansCells
    11. Shiue LH, Alousi AM, Wei C, Hosing CM, Duvic M, Ni X. Augmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease. J Invest Dermatol. 2013 Aug; 133(8):2098-100. PMID: 23519332; PMCID: PMC4477797.
      Citations: 8     Fields:    Translation:HumansCells
    12. Goswami M, Duvic M, Dougherty A, Ni X. Increased Twist expression in advanced stage of mycosis fungoides and S?zary syndrome. J Cutan Pathol. 2012 May; 39(5):500-7. PMID: 22515221; PMCID: PMC3796850.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    13. Shiue LH, Ni X, Prieto VG, Jorgensen JL, Curry JL, Goswami M, Sweeney SA, Duvic M. A case of invisible leukemic cutaneous T cell lymphoma with a regulatory T cell clone. Int J Dermatol. 2013 Sep; 52(9):1111-4. PMID: 22257096.
      Citations: 3     Fields:    Translation:HumansCells
    14. Ni X, Duvic M. Dendritic cells and cutaneous T-cell lymphomas. G Ital Dermatol Venereol. 2011 Apr; 146(2):103-13. PMID: 21505396.
      Citations: 5     Fields:    Translation:HumansCells
    15. Ni X, Richmond HM, Liao XM, Decker WK, Shiue LH, Shpall EJ, Duvic M. Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA. J Invest Dermatol. 2008 Nov; 128(11):2631-2639. PMID: 18480841.
      Citations: 12     Fields:    Translation:HumansCells
    16. Doherty SD, Ni X, Doherty CB, Jones D, Zhao X, Owen LB, Duvic M. Abnormal expression of interleukin-23 in mycosis fungoides/S?zary syndrome lesions. Arch Dermatol Res. 2006 Dec; 298(7):353-6. PMID: 17021762.
      Citations: 5     Fields:    Translation:HumansCells
    17. Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM, Frankel SR. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood. 2007 Jan 01; 109(1):31-9. PMID: 16960145; PMCID: PMC1785068.
      Citations: 368     Fields:    Translation:HumansCellsCTClinical Trials
    18. Zhang C, Richon V, Ni X, Talpur R, Duvic M. Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. J Invest Dermatol. 2005 Nov; 125(5):1045-52. PMID: 16297208.
      Citations: 87     Fields:    Translation:HumansCells
    19. Ni X, Zhang C, Talpur R, Duvic M. Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas. J Invest Dermatol. 2005 Apr; 124(4):741-50. PMID: 15816832.
      Citations: 15     Fields:    Translation:HumansCells
    20. Zhang C, Ni X, Konopleva M, Andreeff M, Duvic M. The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/S?zary syndrome cells. J Invest Dermatol. 2004 Aug; 123(2):380-7. PMID: 15245439.
      Citations: 8     Fields:    Translation:HumansCells
    21. Apisarnthanarax N, Talpur R, Ward S, Ni X, Kim HW, Duvic M. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study. J Am Acad Dermatol. 2004 Apr; 50(4):600-7. PMID: 15034511.
      Citations: 11     Fields:    Translation:HumansCellsCTClinical Trials
    22. Duvic M, Ni X, Talpur R, Herne K, Schulz C, Sui D, Ward S, Joseph A, Hazarika P. Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Invest Dermatol. 2003 Oct; 121(4):902-9. PMID: 14632211.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    23. Zhang C, Hazarika P, Ni X, Weidner DA, Duvic M. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin Cancer Res. 2002 May; 8(5):1234-40. PMID: 12006543.
      Citations: 43     Fields:    Translation:HumansCells
    24. Ni X, Hazarika P, Zhang C, Talpur R, Duvic M. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape? Clin Cancer Res. 2001 Sep; 7(9):2682-92. PMID: 11555580.
      Citations: 16     Fields:    Translation:HumansCells
    25. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4+Foxp3+CD25- T cells in patients with leukemic cutaneous T-cell lymphoma. Photodermatology Photoimmunology and Photomedicine. 31:184-194.
    26. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. Nature Genetics. 47:1426-1434.
    27. Depletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab. OncoImmunology. 4:1-2.
    28. Mogamulizumab in the treatment of cutaneous T cell lymphoma. Expert Opinion on Orphan Drugs. 4:1277-1280.
    NI's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (145)
    Explore
    _
    Co-Authors (16)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _